MoveAgain
Commercial- Indications
- Paralysis, Neurological disorders
Company intelligence / Profile preview
Blackrock Neurotech’s brain-computer interface technologies have enabled patients with paralysis to control computers, robotic arms, communicate via email or text by thought alone, and regain some independence. Their Utah Array has been implanted in over 30 people as part of clinical studies to restore movement or communication. The MoveAgain BCI is their first device designed specifically for clinical use and is progressing toward broader patient access. No large-scale pivotal trial results published yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blackrock Neurotech.